Skip to main content

Table 1 Relationship between the CircPIP5K1A level and clinical characteristics in tissue samples from glioma patients

From: CircRNA PIP5K1A promotes the progression of glioma through upregulation of the TCF12/PI3K/AKT pathway by sponging miR-515-5p

Characteristics

Patients

Expression of CircPIP5K1A

P-value

Low-CircPIP5K1A

High-CircPIP5K1A

Total

45

20

25

 

Age (years)

 <45

20

8

12

0.592

 ≥45

25

12

13

Gender

 Male

24

11

13

0.841

 Female

21

9

12

IDH1 mutation

 No mutation

24

10

14

0.8241

 Mutation

19

9

11

MGMT promoter methylation

 Unmethylation

26

13

12

0.5549

 Methylation

23

10

13

Tumor stage (WHO)

 I-II

27

11

16

0.014*

 III-IV

18

4

14

Ki-67 rate level

 Low

19

13

6

0.0057*

 High

26

7

19

Tumor volume

 <5 cm

28

15

11

0.036*

 ≥5 cm

17

5

14

  1. *P<0.05 was considered to be statically significant